Estimates Revisions Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. Other stock markets 06/07/2026			5-day change	1st Jan Change
1,060.42 ^PKR	+0.55%		+6.26%	+3.71%

05-19	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI
04-30	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. Revenue rev.	1y. EPS revision
HIGHNOON LABORATORIES LIMITED	-	-
ELI LILLY AND COMPANY
JOHNSON & JOHNSON
ABBVIE INC.
ROCHE HOLDING AG
ASTRAZENECA PLC
NOVARTIS AG
NOVO NORDISK A/S
AMGEN INC.
GILEAD SCIENCES, INC.
Average
Weighted average by Cap.